New drug study aims to control rare blood cancer
NCT ID NCT07169331
Summary
This study is testing how well the drug zanubrutinib works and how safe it is for Chinese adults who have just been diagnosed with Waldenström's Macroglobulinemia, a rare blood cancer, and have not yet received any treatment. The goal is to gather more real-world data on the drug's ability to shrink the cancer and control the disease. Participants will take the oral medication and be monitored for their response and any side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for WALDENSTRÖM'S MACROGLOBULINEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Affiliated Hospital of Hebei University
RECRUITINGBaoding, Hebei, 071000, China
-
Nanfang Hospital, Southern Medical University
RECRUITINGGuangzhou, Guangdong, 510515, China
-
Peking Union Medical College Hospital
RECRUITINGBeijing, Beijing Municipality, 100730, China
-
Sun Yat Sen University Cancer Center
RECRUITINGGuangzhou, Guangdong, 510060, China
-
The First Affiliated Hospital, Zhejiang University School of Medicine
RECRUITINGHangzhou, Zhejiang, 310003, China
-
Union Hospital of Tongji Medical College, Huazhong University of Science and Technology
RECRUITINGWuhan, Hubei, 430022, China
-
Xiangya Hospital of Central South University
RECRUITINGChangsha, Hunan, 410008, China
-
Yichang Central Peoples Hospital
RECRUITINGYichang, Hubei, 443003, China
Conditions
Explore the condition pages connected to this study.